A detailed history of Proathlete Wealth Management LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Proathlete Wealth Management LLC holds 169 shares of LLY stock, worth $142,926. This represents 0.04% of its overall portfolio holdings.

Number of Shares
169
Previous 172 1.74%
Holding current value
$142,926
Previous $134 Million 3.78%
% of portfolio
0.04%
Previous 0.04%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 07, 2025

SELL
$625.65 - $812.69 $1,876 - $2,438
-3 Reduced 1.74%
169 $129 Million
Q2 2025

Jul 14, 2025

BUY
$713.71 - $898.95 $32,116 - $40,452
45 Added 35.43%
172 $134 Million
Q1 2025

Apr 21, 2025

BUY
$725.72 - $929.72 $92,166 - $118,074
127 New
127 $105 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $804B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Proathlete Wealth Management LLC Portfolio

Follow Proathlete Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Proathlete Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Proathlete Wealth Management LLC with notifications on news.